The FACTT trial evaluates the impact of conservative versus liberal fluid management strategies on outcomes for patients with Acute Respiratory Distress Syndrome (ARDS). By comparing these approaches, the study reveals that while a conservative strategy—targeting lower central venous or pulmonary artery wedge pressures—does not significantly alter 60-day mortality, it effectively reduces both ventilator dependence and ICU length of stay. Crucially, this restrictive fluid approach does not increase the incidence of shock or end-organ failure, providing clinical validation for the "dry lungs, happy lungs" paradigm. These findings challenge the historical reliance on aggressive fluid resuscitation in critical care, suggesting that limiting fluid intake improves patient recovery metrics without compromising hemodynamic stability. The trial remains a cornerstone in understanding how fluid balance influences pulmonary health and overall morbidity in the intensive care unit.
Sign in to continue reading, translating and more.
Continue